Totect Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Totect General Information

Description

Manufacturer of dexrazoxane product for the treatment of anthracycline extravasation. The company's product is an emergency medicine used to reverse the toxic effects of anthracycline anti-cancer treatment, thereby reducing and avoiding surgical intervention.

Contact Information

Website
www.totect.com
Formerly Known As
Apricus Pharmaceuticals USA
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 100 Enterprise Drive
  • Suite 505
  • Rockaway, NJ 07866
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Clinigen
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 100 Enterprise Drive
  • Suite 505
  • Rockaway, NJ 07866
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Totect Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Totect‘s full profile, request access.

Request a free trial

Totect Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Totect‘s full profile, request access.

Request a free trial

Totect FAQs

  • When was Totect founded?

    Totect was founded in 2007.

  • Where is Totect headquartered?

    Totect is headquartered in Rockaway, NJ.

  • What industry is Totect in?

    Totect’s primary industry is Buildings and Property.

  • Is Totect a private or public company?

    Totect is a Private company.

  • What is Totect’s current revenue?

    The current revenue for Totect is .

  • Who are Totect’s investors?

    Apricus Biosciences, Biocodex USA, and Topotarget have invested in Totect.

  • When was Totect acquired?

    Totect was acquired on 01-Apr-2016.

  • Who acquired Totect?

    Totect was acquired by Clinigen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »